Genomic analysis of high-risk smoldering multiple myeloma
- 13 February 2012
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 97 (9) , 1439-1443
Abstract
Smoldering myeloma is an asymptomatic plasma cell dyscrasia with a heterogeneous propensity to progress to active myeloma. In order to investigate the biology of smoldering myeloma patients with high risk of progression, we analyzed the genomic characteristics by FISH, SNP-arrays and gene expression profile of a group of patients with high-risk smoldering myeloma included in a multicenter randomized trial. Chromosomal abnormalities detected by FISH and SNP-arrays at diagnosis were not associated to risk of progression to symptomatic myeloma. However, the overexpression of four SNORD genes (SNORD25, SNORD27, SNORD30 and SNORD31) was correlated with shorter time to progression (P<0.03). When plasma cells from high-risk smoldering patients who progressed to symptomatic myeloma were sequentially analyzed, newly acquired lesions together with an increase in the proportion of plasma cells carrying a given abnormality were observed. These findings suggest that gene expression profiling is a valuable technique to identify smoldering myeloma patients with high risk of progression. (Clinical Trials NCT00443235).Keywords
This publication has 22 references indexed in Scilit:
- Implication of snoRNA U50 in human breast cancerJournal of Genetics and Genomics, 2009
- A monoclonal gammopathy precedes multiple myeloma in most patientsBlood, 2009
- Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myelomaBlood, 2008
- SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancerHuman Molecular Genetics, 2007
- Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple MyelomaHematology/Oncology Clinics of North America, 2007
- New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cellsBlood, 2007
- Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple MyelomaNew England Journal of Medicine, 2007
- Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosisLeukemia, 2006
- Comparative genomic hybridisation identifies two variants of smoldering multiple myelomaBritish Journal of Haematology, 2005
- MGUS and Smoldering Multiple Myeloma: Update on Pathogenesis, Natural History, and ManagementHematology-American Society Hematology Education Program, 2005